#TotalTox2026

Join us for the ultimate virtual toxicology learning experience with the new and improved ACMT Total Tox Course running in early December on the 3, 4, 10 & 11, 2026! 

Designed for healthcare professionals, this comprehensive virtual event provides cutting-edge knowledge and practical skills across pharmaceuticals, the poisoned patient, substance use, alcohols, emergency and environmental preparedness, and non-pharmaceutical toxicology.

During our live event, you can join the sessions at your convenience, all from the comfort of your home. Miss an exciting lecture? Recordings will be available on-demand for 90 days after the live event!

Access a pre-test before each session to gauge your current toxicological knowledge. During each session, pop-up quizzes and live Q&A sessions will offer unique engagement with speakers and attendees during the live event. At the end, finish your learning experience with a post-test to assess your new knowledge, reviewing your digital Total Tox Collectible cards and claim your CE certificate for each day.

image

Excited for more #TotalTox2026? Register to learn more!

Target Audience

This course is designed for a diverse audience including physicians, pharmacists, advanced practice nurses, nurses, physician assistants, medics, EMTs, SPIs, laboratorians, poison center educators, and first responders. We especially are excited to welcome residents and students eager to expand their expertise in the world of Medical Toxicology!

Group Discounts Available
Is your hospital or medical group interested in enrolling multiple employees in our course? We offer special discounts for organizations with multiple participants. Contact us at [email protected] for more details!

Register for the Complete Course - Save $150!

Are you a member of any of these organizations (but not a member of ACMT) AAEM, AAENP, AHEPP, APC, APAMT, DrugImpairment.com, EAPCCT, or MENATOX? You are eligible for a registration discount! Please email us at [email protected] for more information.

Register for Individual Sessions

Each activity can be purchased individually and is accredited and with its own Continuing Education certificate.

Want to attend just two sessions? Interested in two days? Add two courses directly to your cart and receive an automatic discount of $50!

CE Credit available
Product Image: The Poisoned Patient & Analgesic/OTC Toxicology | 2026 Total Tox
The Poisoned Patient & Analgesic/OTC Toxicology | 2026 Total Tox
Acetaminophen, Antidote administration, Antimicrobials, Anticholinergics, Household Agents, Iron, Nonsteroidal anti-inflammatories, Nutritional supplements, Toxidromes, Salicylates and more!
CE Credit available
Product Image: Neuropsychiatric & Cardiovascular Pharmaceutical Toxicity | 2026 Total Tox
Neuropsychiatric & Cardiovascular Pharmaceutical Toxicity | 2026 Total Tox
Antiarrhythmics, Anticoagulants/Antithrombotics, Anticonvulsants, Antidepressants, Antihypertensives, Antipsychotics, Beta blockers, Calcium channel blockers, Lithium, Local anesthetics, Methemoglobinemia, SSRI's and more!
CE Credit available
Product Image: Environmental & Disaster Preparedness | 2026 Total Tox
Environmental & Disaster Preparedness | 2026 Total Tox
Arthropods, Marine organisms, Reptiles, Radiation Emergencies, Biological Warfare Agents, Environmental exposures, Carbon monoxide, Cholinergics, Heavy metals, Herbicides, insecticides, rodenticides, Hydrocarbons, mushrooms and more!
CE Credit available
Product Image: Substance Use, Toxicology Pitfalls & Alcohols | 2026 Total Tox
Substance Use, Toxicology Pitfalls & Alcohols | 2026 Total Tox
Alcohol use disorder, Substance Use Disorders, Illicit drug use, Prescription drug use, Withdrawal syndromes, Ethanol, Ethylene glycol, Methanol, Cannabis, Sedatives, Hypnotics, Stimulants and more!

Core Content Discused

Our expert-led activities will cover a comprehensive range of topics, including EM Core Content and CSPI Core Content like:


Session 1 | The Poisoned Patient & Analgesic/OTC Toxicology

EM Core Content
1.3.54 (Toxidromes) 1.3.36 (Poisoning)
 4.7.3 (Stevens-Johnson syndrome)
4.7.4 (Toxic epidermal necrolysis) 5.4.1.1 (Complications in glucose metabolism) 16.5.2 (Toxic effects of gases, fumes, vapors)
17.1.2.1 (Acetaminophen) 17.1.2.2 (Nonsteroidal anti-inflammatories) 17.1.2.4 (Salicylates)
17.1.3 (Anticholinergics) 17.1.8 (Antimicrobials) 17.1.16 (Household/Industrial agents
(caustic agents, hydrocarbons, inhaled irritants)
17.1.17 (Hypoglycemics/insulin) 17.1.23.1 (Iron) 17.1.23.2 (Performance enhancing and weight loss drugs)
17.1.26 (Stimulants/Sympathomimetics) 19.4.11.1 (Decontamination)
 19.4.11.2 (Antidote administration)
CSPI Core Content
1.1 (Given an exposure in which the symptoms and signs do not support the original history, identify the causal agent(s).) 1.4 (Identify plausible or implausible, age-appropriate exposure scenarios.)
1.5 (Given an exposure scenario (ingestion, ocular, dermal, or inhalation) , identify the questions that should be asked about the symptoms and signs.) 1.7 (Given a patient with specific symptoms who is taking a particular medication, identify what additional history should be obtained.)
2.1 (Given a patient exposed to an amount of a gel, liquid or cream in specific concentrations, calculate the ingested dose on an amount per weight dosage.) 2.2 (Given an exposure including a patient who has taken an unknown amount of a substance, determine the amount of substance that would need to be ingested to reach a defined toxic dose.)
2.3 (Given an exposure including a patient who has taken a known amount of a solid substance, calculate the amount ingested on an amount per weight dosage.) 2.4 (Convert units of measurement for common exposures.)
6.2 (Identify the toxicity and symptoms of exposure to analgesics including over-the-counter or prescription.) 6.6 (Identify the toxicity and symptoms of exposure to antimicrobials.)
6.11 (Identify the toxicity and symptoms of exposure to over-the-counter stimulants and weight-loss preparations.) 6.12 (Identify the toxicity and symptoms of exposure to antidiabetic agents.)
6.14 (Identify the toxicity and symptoms of exposure to iron.) 6.20 (Identify the toxicity and symptoms of exposure to over-the-counter topicals.)
6.21 (Identify the toxicity and symptoms of exposure to vitamins.) 7.1 (Given an exposure, identify household products which may cause significant toxicity in small amounts.)
7.4 (Identify the toxicity and symptoms of exposure to cleaning substances.) 7.6 (Identify the toxicity and symptoms of exposure to hydrocarbons.)
9.3 (Given an exposure, identify the anticholinergic toxidrome or the causative agent.

Session 2 | Neuropsychiatric & Cardiovascular Pharmaceutical Toxicity

EM Core Content
17.1.4 (Anticoagulants/Antithrombotics) 17.1.5 (Anticonvulsants)
 17.1.6 (Antidepressants)
17.1.6.2 (Selective serotonin reuptake inhibitors) 17.1.9 (Antipsychotics) 17.1.11.1 (Antiarrhythmics)
17.1.11.2 (Antihypertensives) 17.1.11.3 (Beta blockers) 17.1.11.4 (Calcium channel blockers)
17.1.18 (Lithium) 17.1.19 (Local anesthetics) 17.1.21 and 8.5.3 (Methemoglobinemia)
CSPI Core Content
6.3 (Identify the toxicity and symptoms of exposure to anticonvulsants.) 6.7 (Identify the toxicity and symptoms of exposure to antipsychotic agents.)
6.4 (Identify the toxicity and symptoms of exposure to non-cyclic antidepressants.) 6.5 (Identify the toxicity and symptoms of exposure to tricyclic antidepressants.)
6.8 (Identify the toxicity and symptoms of exposure to common antihypertensives.) 6.9 (Identify the toxicity and symptoms of exposure to beta blockers and calcium channel antagonists.)
6.18 (Identify the toxicity and symptoms of exposure to cocaine.) 6.22 (Given an exposure to a beta blocker or calcium channel blocker, identify the appropriate treatment.)
9.5 (Given an exposure, identify the methemoglobinemia toxicologic syndrome or the causative agent.) 9.7 (Identify the treatment for methemoglobinemia.

Session 3 | Environmental & Disaster Preparedness

EM Core Content
6.1.1 (Arthropods) 6.1.3 (Marine organisms) 6.1.4 (Reptiles)
6.7 (Radiation Emergencies) 10.2 (Biological Warfare Agents) 16.5.2 (Toxic effects of gases, fumes, vapors)
16.4.6 (Environmental/Industrial exposure) 17.1.10 (Carbon monoxide) 17.1.12 (Cholinergics)
17.1.13 (Cyanides, hydrogen sulfide) 17.1.14 (Heavy metals) 17.1.15 (Herbicides, insecticides, and rodenticides)
17.1.16 (Household/Industrial chemicals) 17.1.16.2 (Hydrocarbons) 17.1.16.3 (Inhaled irritants)
17.1.20 (Marine toxins) 17.1.22 (Mushrooms/Poisonous plants) 18.1.3.2 (Bite wounds)
18.1.3.3.2 (Chemical Burns) 18.1.3.3.4 (Radiation Burns) 18.1.10.2 (Corneal Burns)
19.4.11.1 (Decontamination)
CSPI Core Content
1.5 (Given an exposure scenario (ingestion, ocular, dermal, or inhalation) , identify the questions that should be asked about the symptoms and signs.) 3.6 (Identify the appropriate decontamination method for a given exposure (gastrointestinal, dermal, ocular, or inhalation)
4.1 (Given an exposure, identify which plant is responsible) 4.2 (Given an exposure, identify which mushroom class is responsible.)
4.5 (Identify the toxicity and symptoms of a bite from a snake species indigenous to North America.) 5.1 (Given an inhalation exposure, identify which substance is responsible.)
5.2 (Given a cyanide exposure, identify the appropriate treatment.) 5.3 (Identify the toxicity and symptoms of chemical exposures.)
5.5 (Identify the toxicity and symptoms from carbon monoxide exposure.) 5.6 (Identify the toxicity and symptoms of exposure to heavy metals.)
5.7 (Given a dermal exposure to caustic chemicals, identify the appropriate treatment.) 5.8 (Given a cyanide exposure, identify the appropriate treatment.)
8.1 (Given an exposure, identify the insecticide or herbicide that is potentially responsible.) 8.2 (Identify the toxicity and symptoms of exposure to carbamates and organophosphates.)
8.3 (Identify the toxicity and symptoms of exposure to insect repellents.) 8.4 (Given a pesticide exposure, identify the appropriate treatment.)
8.5 (Given a rodenticide exposure, identify the appropriate treatment.)

Session 4 | Substance Use, Toxicology Pitfalls & Alcohols

EM Core Content
14.1 (Substance Use Disorders) 14.1.1 (Alcohol use disorder) 14.1.2 (Illicit drug use)
14.1.3 (Prescription drug use) 14.1.5 (Withdrawal syndromes) 17.1.1.1 (Ethanol)
17.1.1.2 (Ethylene glycol) 17.1.1.3 (Isopropyl) 17.1.1.4 (Methanol)
17.1.24 (Recreational drugs) 17.1.24.1 (Cannabis) 17.1.24.1.1 (Cannabinoid hyperemesis syndrome)
17.1.25 (Sedatives/Hypnotics) 17.1.26 (Stimulants/Sympathomimetics)
CSPI Core Content
1.7 (Given a patient with specific symptoms who is taking a particular medication, identify what additional history should be obtained.) 3.9 (Given an exposure, identify appropriate monitoring parameters.)
6.15 (Identify the toxicity and symptoms of exposure to sedative hypnotics.) 6.18 (Identify the toxicity and symptoms of exposure to cocaine.)
6.19 (Identify the toxicity and symptoms of exposure to street drugs.) 7.2 (Identify the toxicity and symptoms of exposure to ethanol and isopropyl alcohol.)
7.3 (Identify the toxicity and symptoms of exposure to ethylene glycol and methanol.) 7.9 (Identify the treatment for ethylene glycol or methanol poisoning.)
9.4 (Given an exposure, identify the opioid toxidrome or the causative agent.) 10.5 (Given results of a urine drug screen, identify potential false positive or false negatives.)
10.7 (Given an exposure, identify which lab or ancillary test(s) should be analyzed.)

Disclaimer

This course was developed independently of the American Board of Emergency Medicine (ABEM) Certification Exam and the Certified Specialist in Poison Information (CSPI) Exam. Faculty and planning committee members did not use privileged examination information to develop or tailor any course content.

Educational materials, including lectures, visual study materials, topic slides, and pre- and post-test questions, are based on the expertise and clinical experience of ACMT members and other subject matter experts. Any EM Core Content or CSPI Core Content topics are provided only as a reference to lecture content and do not represent definitive examination content.

These materials are intended to support toxicology education and examination preparation but are not representative of or predictive of the content or format of any examinations.